Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: Results of a double-blinded randomized controlled trial

Annals of Surgery

Volumn 249, Issue 3, 2009, Pages 355-363

  Ryan, Aoife M ^a   Reynolds, John V ^a   Healy, Laura ^a   Byrne, Miriam ^a   Moore, Jennifer ^a   Brannelly, Niamh ^a   McHugh, Aisling ^a   McCormack, Deirdre ^a   Flood, Philomena ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

Anabolism; Eicosapentaenoic acid; Enteral feeding; Esophagectomy; Omega 3

Indexed keywords

CYTOKINE; D DIMER; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANASTOMOTIC LEAK; ARM; ARTICLE; BLOOD CLOTTING; BODY COMPOSITION; BODY FAT; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; IMMUNE RESPONSE; IMPEDANCE; INFLAMMATION; KIDNEY FAILURE; LEAN BODY WEIGHT; LEG; MALE; METABOLISM; NUTRITION; NUTRITIONAL SUPPORT; PERIOPERATIVE PERIOD; PERIPHERAL BLOOD MONONUCLEAR CELL; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SEPSIS; STRESS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE; TRUNK; WOUND INFECTION; AGED; BODY MASS; DIET SUPPLEMENTATION; DRUG EFFECT; ESOPHAGUS TUMOR; MIDDLE AGED; NUTRITIONAL STATUS; WEIGHT REDUCTION;

AGED; BODY COMPOSITION; BODY MASS INDEX; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; ELECTRIC IMPEDANCE; ENTERAL NUTRITION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; WEIGHT LOSS;

EID: 63449140457     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31819a4789     Document Type: Article

References (41)

1. Bailey SH, Bull DA, Harpole DH, Rentz JJ, Neumayer LA, Pappas TN, Daley J, Henderson WG, Krasnicka B, Khuri SF. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thoracic Surg. 2003;75(1): 217-222.
2. Enzinger PC, Mayer RJ. Oesophageal cancer. New Eng J Med. 2003;349: 2241-2252.
3. Bosset J-F, Gignoux M, Tiboulet J-P, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. New Eng J Med. 1997;337:161-167.
4. Reynolds JV, Ravi N, Hollywood D, Kennedy MJ, Rowley S, Ryan A, Hughes N, Carey M, Byrne PJ. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy. J Thorac Cardiovasc Surg. 2006a;132(3):549-555.
5. Lagergren P, Avery KN, Hughes R, Barham CP, Alderson D, Falk SJ, Blazeby JM. Health Related Quality of Life among patients cured by surgery for esophageal cancer. Cancer. 2007;110(3):686-693.
6. Reynolds JV, McLaughlin R, Moore J, Rowley S, Ravi N, Byrne PJ. Prospective evaluation of quality of life in patients with localised oesophageal cancer treated by multimodal therapy or surgery alone. Br J Surg. 2006b; 93(9):1084-1090.
7. Traverso LW, Shinchi H, Low DE. Useful benchmarks to evaluate outcomes after esophagectomy and pancreaticoduodenectomy. Am J Surg. 2004;187(5): 604-608.
8. Ryan A, Rowley S, Healy L, Flood P, Ravi N, Reynolds JV. Post Oesophagectomy early enteral nutrition via a needle catheter jejunostomy: 8 year experience at a specialist unit. Clin Nutr. 2006;25(3):386-393.
9. Beier-Holgerson R, Boesby S. Influence of postoperative enteral nutrition on post-surgical infections. Gut. 1996;39(96):833-835.
10. Hockwald SN, Harrison LE, Heslin MJ, Burt ME, Brennan MF. Early post operative enteral feeding improves whole body protein kinetics in upper gastrointestinal cancer patients. Am J Surg. 1997;174(3):324-330.
11. Xu J, Zhong Y, Jing D, Wu Z. Pre operative enteral immunonutrition improves post operative outcomes in patients with gastrointestinal cancer. W J Surg. 2006;30:1284-1289.
12. Zheng Y, Li F, Qi B, Luo B, Sun H, Liu S, Wu X. Application of peri-operative immunonutrition for gastrointestinal surgery: a meta-analysis of randomised controlled trials. Asia Pac J Clin Nutr. 2007;16(S1):253-257.
13. Fritsche K. Fatty Acids as Modulators of the Immune Response. Ann Rev Nutr. 2006;26:45-73.
14. Barber MD, Fearon KCH, Tisdale MJ, McMillan DC, Ross JA. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatric cancer cachexia. Nutr Cancer. 2001;40(2):118-124.
15. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophago-gastric junction. Br J Surg. 1998;85:1457-1459.
16. Reynolds JV, Muldoon C, Hollywood D, Ravi N, Rowley S, O'Byrne K, Kennedy J, Murphy TJ. Long-term outcomes following neoadjuvant chemo-radiotherapy for esophageal caner. Ann Surg. 2007;245(5):707-716.
17. Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. J Parent Ent Nutr. 1977;1(1):11-22.
18. World Health Organisation Consultation on Obesity. Preventing and managing the global epidemic: Report of a WHO consultation on Obesity, Geneva, 3-5 June 1997, 1-276 Geneva, Switzerland, WHO. 1998.
19. Veterans Affairs Total Parenteral Nutrition Cooperative Study Group 1991. Perioperative total Parenteral nutrition in surgical patients. New Eng J Med. 1991;325:525-532.
20. Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr. 1985;39, Suppl 1:5-41.
21. Elia M. Artificial nutrition support. Med Int. 1990;82:3392-3396.
22. Bone RC, Sibbald WJ, Spring CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest. 1992;101:1481-1483.
23. Desborough JP. The stress response to Trauma and surgery. Br J Anaesth. 2000;85(1):109-117.
24. Sweeney KJ, Kell MR, Ravi N, Reynolds JV. Major Upper Gastrointestinal Surgery is associated with an antigen-dependent proinflammatory T cell response. Br J Surg. 2005;92(8):989-995.
25. Avery KN, Metcalfe C, Barham CP, Alderson D, Falk SJ, Blazeby JM. Quality of Life during potentially curative treatment for locally advanced oesophageal cancer. Br J Surg. 2007;94(11):1369-1376.
26. Martin L, Lagergren J, Lindblad M, Rouvelas I, Lagergren P. Malnutrition after cancer surgery in Sweden. Br J Surg. 2007;94(12):1496-1500.
27. Senkal M, Haker R, Linseisin J, Wolfram G, Homann HH, Stehle P. Preoperative oral supplementation with long chain omega 3 fatty acids beneficially alters phospholipids fatty acid patterns in liver, gut mucosa and tumour tissue. J Parent Ent Nutr. 2005;29(4):236-240.
28. Suchner U, Kuhn KS, Furst P. The scientific basis of immunonutrition. Proceedings of the Nutrition Society. 2000;59:553-563.
29. Ruis NM, Rose JK, Valone FH. Tumour necrosis factor release by human monocytes stimulated with platelet-activating factor. Lipids. 1991;26:1060-1604.
30. Barber MD, McMillan DC, Preston T, Ross JA, Fearon KC. Metabolic response to feeding in weight losing pancreatic cancer patients and it's modulation by a fish oil enriched nutritional supplement. Clinical Science. 2000;98:389-399.
31. Fearon KCH, Von Meyenfeldt M, Moses AGW. An energy and protein dense, high n-3 fatty acid oral supplement promotes weight gain in cancer cachexia. Eur J Can. 2001;37:S27-S28.
32. Lorite MJ, Cariuk P, Tisdale P.J. Induction of muscle protein degradation by a tumour factor. Br J Cancer 1997;76(8):1035-1040.
33. Bone RC. Sepsis and its complications: the clinical problem. Crit Care Med. 1994;22:S8-S11.
34. Wang LS, Lin HY, Chang CJ, Fahn HJ, Huang MH, Lin CFJ. Effects of enbloc oesophagectomy on nutritional and immune status in patients with esophageal carcinoma. J Surg Oncol. 1998;76:90-98.
35. Drost AC, Burleson DG, Cioffi WG Jr. Plasma cytokines after thermal injury and their relationship on infection. Ann Surg. 1993;218:74-80.
36. Aiko S, Yoshizumi Y, Tsuwano S, Shimanouchi M, Sugiura Y, Machara T. The Effects of immediate enteral feeding with a formula containing high levels of omega-3 fatty acids in patients after surgery for esophageal cancer. J Parent Ent Nutr. 2005;29(3):141-147.
37. Coceani F, Akarus ES. Prostaglandin E2 in the pathogenesis of fever: an update. Ann New York Acad Sci. 1998;856:48-52.
38. Klava A, Windsor ACJ, Farmery SM, Reynolds JV, Guillou PJ. Interleukin-10. A role in the development of postoperative immunosuppression. Arch Surg. 1997;132:425.
39. Caughey GE, Mantzoris E, Gibson RA, Cleland LG, James MJ. The effect on tumour necrosis factor alpha and interleukin 1 beta production of diets enriched with n-3 fatty acids from vegetable and fish oil. Am J Clin Nutr. 1996;63:116-122.
40. Azim K, McManus R, Brophy K, Ryan A, Kelleher D, Reynolds JV. Genetic Polymorphisms and the risk of infection following esophagectomy: positive association with Tumour Necrosis Factor alpha gene 308. Ann Surg. 2007; 246(1):122-128.
41. Grimble RF. Nutritional modulation of immune function. Proc Nutr Soc. 2001;60:389-397.